CAMPOSTRINI, Natascia
 Distribuzione geografica
Continente #
NA - Nord America 2.789
EU - Europa 2.206
AS - Asia 1.090
SA - Sud America 46
AF - Africa 6
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.144
Nazione #
US - Stati Uniti d'America 2.781
GB - Regno Unito 848
CN - Cina 665
SG - Singapore 305
SE - Svezia 240
FR - Francia 212
IE - Irlanda 181
RU - Federazione Russa 178
FI - Finlandia 167
DE - Germania 162
IT - Italia 100
UA - Ucraina 58
BR - Brasile 35
JP - Giappone 32
BE - Belgio 24
HK - Hong Kong 20
IN - India 17
TR - Turchia 13
NL - Olanda 10
IR - Iran 9
CA - Canada 7
AU - Australia 5
KR - Corea 5
AR - Argentina 3
AT - Austria 3
CH - Svizzera 3
EC - Ecuador 3
ES - Italia 3
GR - Grecia 3
HR - Croazia 3
IL - Israele 3
CL - Cile 2
EG - Egitto 2
EU - Europa 2
KG - Kirghizistan 2
LT - Lituania 2
MD - Moldavia 2
MY - Malesia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
IM - Isola di Man 1
IQ - Iraq 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
ME - Montenegro 1
MU - Mauritius 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
SA - Arabia Saudita 1
TM - Turkmenistan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 6.144
Città #
Southend 733
Chandler 513
Jacksonville 478
Woodbridge 340
Singapore 237
Ann Arbor 234
Houston 194
Dublin 181
Ashburn 124
Beijing 119
Lawrence 77
Princeton 77
Wilmington 69
New York 66
Lancaster 63
Nanjing 61
Jinan 58
Boardman 38
Verona 37
Shenyang 34
Tokyo 32
Helsinki 30
Nanchang 25
Brussels 22
Hebei 22
Munich 21
Sindelfingen 21
Changsha 20
Jiaxing 20
Haikou 19
Zhengzhou 19
Hangzhou 18
Guangzhou 16
Milan 16
Ningbo 16
Norwalk 16
Hong Kong 15
Taizhou 15
Tianjin 14
Santa Clara 13
Taiyuan 13
Redmond 12
Lanzhou 10
Fairfield 9
London 9
San Mateo 9
Seattle 9
Fuzhou 8
Dearborn 7
Ardabil 6
Dallas 6
Falls Church 6
Los Angeles 6
Toronto 6
Bologna 5
Washington 5
Düsseldorf 4
Kochi 4
Nettuno 4
Shanghai 4
Aligarh 3
Athens 3
Bangalore 3
Chennai 3
Chicago 3
Clearwater 3
Detroit 3
Groningen 3
Madrid 3
Nuremberg 3
Seoul 3
Vienna 3
Zagreb 3
Zurich 3
Augusta 2
Berlin 2
Bishkek 2
Buffalo 2
Cairo 2
Cambridge 2
Centurion 2
Chengdu 2
Chisinau 2
Columbus 2
Council Bluffs 2
Frankfurt am Main 2
Harbin 2
Kent 2
Kish 2
Las Vegas 2
Leawood 2
Monmouth Junction 2
Moscow 2
Paris 2
San Francisco 2
Sydney 2
São Paulo 2
Tashkent 2
Venice 2
Waanrode 2
Totale 4.359
Nome #
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 129
The proteome: anno Domini 2002 120
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 120
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 116
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 108
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 105
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 105
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 104
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 103
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 100
A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells. 99
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian Patients with Iron Overload and Non-Diagnostic First Level Genetic Test: A Pilot Study 99
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 98
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 98
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 98
“Proteomics approaches for studying chemoresistance in cancer” 97
Altered paraoxonase expression in patients with genetic haemochromatosis. 97
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 95
Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing. 95
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 93
“Application of Partial Least Squares Discriminant Analysis and variable selection procedures: a 2D-PAGE Proteomic-Based Study” 93
“Pre-fractionation for Hidden Proteome” 92
Hepcidin levels and their determinants in different types of myelodysplastic syndromes. 92
"Quantitative Proteomics" 91
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 91
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 90
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 90
TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals. 90
Anticancer activity of a novel histone deacetylase inhibitor against human colorectal cancer cells 90
Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. 88
Serum Hepcidin Levels Correlate with Phenotypes of the Metabolic Syndrome At Population Level 88
MOLECULARLY IMPRINTED NANOPARTICLES FOR HEPCIDIN CAPTURE: A SYNTHETIC ALTERNATIVE TO NATURAL ANTIBODIES 88
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 87
“Numerical approaches for quantitative analysis of 2D map: a review of commercial software and of “home-made” systems” 86
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 86
Quantitative proteomics: a review of different methodologies. 85
Acquired iron overload associated with antitransferrin monoclonal immunoglobulin: a case report. 84
Association ofHFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations. 84
Proteomic analysis of an orthotopic neuroblastoma xenograft animal model. 83
Serum Hepcidin in Inflammatory Bowel Diseases: biological and clinical significance. 82
High-protein goat's milk diet identified through newborn screening: clinical warning of a potentially dangerous dietetic practice 82
Proteomic analysis of S-nitrosylated proteins in Arabidopsis thaliana undergoing hypersensitive response 80
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 79
Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. 79
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 78
Reduced serum hepcidin levels in patients with chronic hepatitis C 78
Does TMPRSS6 RS855791 Polymorphism Contribute to Iron Deficiency in Treated Celiac Disease? 75
Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron. 74
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis. 74
Study of proteomic changes associated with healthy and tumoral murine samples in neuroblastoma by principal component analysis and classification methods. 70
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 69
Proteomic analysis of S-nitrosylated proteins in Arabidopsis during the disease resistance response 69
Urinary hepcidin identifies a serum ferritin cut-off for iron supplementation in young athletes: a pilot study. 69
Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity 69
Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin 68
PON1 activity and coagulation biomarkers: no association with thrombin generation parameters but an inverse correlation with D-dimer plasma concentration 65
Spot overlapping in two-dimensional maps: a serious problem ignored for much too long. 64
Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience 64
Newborn Screening for Biotinidase Deficiency. The Experience of a Regional Center in Italy 63
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 62
Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease 62
A Gain-of-Function Mutation on BCKDK Gene and Its Possible Pathogenic Role in Branched-Chain Amino Acid Metabolism 61
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 59
Formation of truncated proteins and high-molecular-mass aggregates upon soft illumination of photosynthetic proteins. 59
Proteomic analysis of anti-angiogenic effects by a combined treatment with vinblastine and rapamycin in an endothelial cell line. 58
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients. 58
Iron deficiency in the elderly population, revisited in the hepcidin era. 58
Hepcidin levels in chronic hemodialysis patients: a critical evaluation. 56
Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material 56
Two-dimensional mapping as a tool for classification of green coffee bean species. 54
Omics | quantitative proteomics 54
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization 52
Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo 52
Targeted Next Generation Sequencing of the Five Hemochromatosis Genes in Italian patients with Iron Overload and Non-diagnostic First Level Genetic Test.A Pilot Study 49
Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo. 45
Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA) 42
Vitamin B12 Administration by Subcutaneous Catheter Device in a Cobalamin A (cblA) Patient 36
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 16
Totale 6.197
Categoria #
all - tutte 22.933
article - articoli 16.992
book - libri 0
conference - conferenze 4.745
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.196
Totale 45.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020218 0 0 0 0 0 0 0 0 28 81 40 69
2020/2021629 59 107 29 75 102 62 9 45 34 11 88 8
2021/2022547 34 145 11 65 20 16 6 27 20 15 62 126
2022/20231.345 90 142 129 216 146 317 23 79 156 4 27 16
2023/2024603 24 48 39 51 76 126 14 35 4 11 120 55
2024/2025767 67 103 63 274 62 68 60 46 24 0 0 0
Totale 6.197